Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investmentsNEWARK, N.J., Dec. 14, 2023 -- Rafael Holdings,...

Related Keywords

Barbara Ryan ,Other Pharmaceuticals ,Cyclo Therapeutics Inc ,Day Three Labs Inc ,Rafael Holdings Inc ,Rafael Holdings ,Cornerstone Pharmaceuticals Inc ,Nasdaq ,Rafael Medical Devices ,Barer Institute Inc ,Barer Institute ,Lipomedix Pharmaceuticals Ltd ,Rafael Pharmaceuticals Inc ,Bill Conkling ,Cyclo Therapeutics ,Day Three Laboratories ,First Quarter Fiscal Year ,Cornerstone Pharmaceuticals ,Day Three Labs ,Private Securities Litigation Reform Act ,Annual Report ,Months Ended October ,Markets ,